EPO and triple-A syndrome: The incidence of AAA was 0%, 55%, 35%, 10%, and 55% in the vehicle group, EPO group, EPO+low‐dose formoterol group, EPO+medium‐dose formoterol group, and EPO+high‐dose formoterol group, respectively (Figure 2D).